Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 757 of 1,261

  1. US 9012506

    Cross-linked fatty acid-based biomaterials

    ATRIUM MEDICAL CORPORATION · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  2. US 9012434

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  3. US 9012455

    Pharmaceutical compositions containing an indoyl isoquinoline containing compound and uses thereof

    The Regents of the University of California · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  4. US 9012407

    Therapies which act on neuropeptide S receptors

    The Regents of the University of California · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  5. US 9012225

    Lipophilic polynucleotide conjugates

    MIRAGEN THERAPEUTICS, INC. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  6. US 9012594

    Catalyst and byproduct-free native chemical ligation using cyclic thioester precursors

    Northwestern University · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  7. US 9011925

    Method for preparing polysaccharide nanocomposite particles and uses of the same

    China Medical University · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  8. US 9011919

    Compositions for targeted delivery of siRNA

    Arrowhead Madison, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  9. US 9012134

    CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs

    The Regents of the University of California · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  10. US 9011888

    Organic-inorganic composite particles, process for producing the same, dispersion containing the particles, and cosmetic containing the particles

    JGC Catalysts and Chemicals Ltd. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  11. US 9011926

    Method for producing granules

    Takeda Pharmaceutical Company Limited · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  12. US 9011834

    Compositions and methods

    Seres Health, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  13. US 9011874

    Compositions, methods and uses for poxvirus elements in vaccine constructs

    Takeda Vaccines, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  14. US 9006201

    Prophylactic or therapeutic agent for diabetes

    Takeda Pharmaceutical Company Limited · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  15. US 9006473

    Nitrated lipids and methods of making and using thereof

    University College Cardiff Consultants Limited · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  16. US 9008184

    Multiple sign bit hiding within a transform unit

    BlackBerry Limited · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  17. US 9006399

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  18. US 9006462

    Glycopyrrolate salts

    Dermira, Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  19. US 9006290

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  20. US 9006239

    2-aryl-4-quinazolinones and their pharmaceutical compositions

    China Medical University · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  21. US 9006219

    Oligomer-foscarnet conjugates

    Nektar Therapeutics · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  22. US 9006203

    Method of reducing inflammatory infiltration in subjects with inflammatory lung disease

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  23. US 9005964

    Endodermal progenitor cells

    Regents of the University of Minnesota · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  24. US 9006197

    Compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Alnylam Pharmaceuticals, Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.